Work

Nivolumab + chemotherapy vs chemotherapy in EGFR-mutated NSCLC after 1L or 2L EGFR-TKIs (CheckMate 722)

Year: 2019

Type: article

Study design: Study Protocol

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz343.039

Authors: Keunchil Park, James Chih-Hsin Yang, Nicolas Girard, Tony Mok, Justin Gainor, Kazuhiko Nakagawa, Yi-Long Wu, Wanning Xu, Rong Yang, Yuichiro Ohe

Institutions: Samsung Medical Center, Sungkyunkwan University, National Taiwan University Hospital, Institut Curie, Chinese University of Hong Kong, Massachusetts General Hospital, Kindai University Hospital, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Bristol-Myers Squibb (United States), National Cancer Center Hospital East

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2979385751

FWCI: 1.102

Cites:

Cited by: 7

Related to: 10